Cargando…

Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”

Extracellular vesicles (EVs) are globular, membrane bound nanovesicles (30–100 nm range) that are shed both during normal cellular functioning and under pathological conditions by most cell types. In recent years, there has been significant interest in the study of these vesicles as conduits for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Guoku, Witwer, Kenneth W., Bond, Vincent C., Haughey, Norman, Kashanchi, Fatah, Pulliam, Lynn, Buch, Shilpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373676/
https://www.ncbi.nlm.nih.gov/pubmed/28800366
http://dx.doi.org/10.1080/20013078.2017.1294360
_version_ 1782518805234188288
author Hu, Guoku
Witwer, Kenneth W.
Bond, Vincent C.
Haughey, Norman
Kashanchi, Fatah
Pulliam, Lynn
Buch, Shilpa
author_facet Hu, Guoku
Witwer, Kenneth W.
Bond, Vincent C.
Haughey, Norman
Kashanchi, Fatah
Pulliam, Lynn
Buch, Shilpa
author_sort Hu, Guoku
collection PubMed
description Extracellular vesicles (EVs) are globular, membrane bound nanovesicles (30–100 nm range) that are shed both during normal cellular functioning and under pathological conditions by most cell types. In recent years, there has been significant interest in the study of these vesicles as conduits for the delivery of information between cells from both analogous and disparate tissues. Their ability to carry specialised cargo including signalling mediators, proteins, messenger RNA and miRNAs characterises these vesicles as primary facilitators of cell-to-cell communication and regulation. EVs have also been demonstrated to play important roles in the field of cancer biology and metastasis. However, significant knowledge gaps exist in the role these vesicles play in the context of HIV infection and drug abuse. To foster discussion in this area a satellite symposium on “HIV, NeuroAIDS, Drug Abuse & EVs”, was held in conjunction with the annual meeting of the International Society for Extracellular Vesicles (ISEV) in Bethesda, in April 2015. Experts in HIV and drug abuse fields were invited to share their findings on the role of EVs in HIV-1 infection and drug addiction. Additional discussion included current areas of research in EV biology in HIV infection and drug abuse.
format Online
Article
Text
id pubmed-5373676
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-53736762017-04-06 Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs” Hu, Guoku Witwer, Kenneth W. Bond, Vincent C. Haughey, Norman Kashanchi, Fatah Pulliam, Lynn Buch, Shilpa J Extracell Vesicles Meeting Report Extracellular vesicles (EVs) are globular, membrane bound nanovesicles (30–100 nm range) that are shed both during normal cellular functioning and under pathological conditions by most cell types. In recent years, there has been significant interest in the study of these vesicles as conduits for the delivery of information between cells from both analogous and disparate tissues. Their ability to carry specialised cargo including signalling mediators, proteins, messenger RNA and miRNAs characterises these vesicles as primary facilitators of cell-to-cell communication and regulation. EVs have also been demonstrated to play important roles in the field of cancer biology and metastasis. However, significant knowledge gaps exist in the role these vesicles play in the context of HIV infection and drug abuse. To foster discussion in this area a satellite symposium on “HIV, NeuroAIDS, Drug Abuse & EVs”, was held in conjunction with the annual meeting of the International Society for Extracellular Vesicles (ISEV) in Bethesda, in April 2015. Experts in HIV and drug abuse fields were invited to share their findings on the role of EVs in HIV-1 infection and drug addiction. Additional discussion included current areas of research in EV biology in HIV infection and drug abuse. Taylor & Francis 2017-03-10 /pmc/articles/PMC5373676/ /pubmed/28800366 http://dx.doi.org/10.1080/20013078.2017.1294360 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Report
Hu, Guoku
Witwer, Kenneth W.
Bond, Vincent C.
Haughey, Norman
Kashanchi, Fatah
Pulliam, Lynn
Buch, Shilpa
Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
title Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
title_full Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
title_fullStr Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
title_full_unstemmed Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
title_short Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
title_sort proceedings of the isev symposium on “hiv, neuroaids, drug abuse & evs”
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373676/
https://www.ncbi.nlm.nih.gov/pubmed/28800366
http://dx.doi.org/10.1080/20013078.2017.1294360
work_keys_str_mv AT huguoku proceedingsoftheisevsymposiumonhivneuroaidsdrugabuseevs
AT witwerkennethw proceedingsoftheisevsymposiumonhivneuroaidsdrugabuseevs
AT bondvincentc proceedingsoftheisevsymposiumonhivneuroaidsdrugabuseevs
AT haugheynorman proceedingsoftheisevsymposiumonhivneuroaidsdrugabuseevs
AT kashanchifatah proceedingsoftheisevsymposiumonhivneuroaidsdrugabuseevs
AT pulliamlynn proceedingsoftheisevsymposiumonhivneuroaidsdrugabuseevs
AT buchshilpa proceedingsoftheisevsymposiumonhivneuroaidsdrugabuseevs